Open AccessNilotinib: selective inhibitor as second-line therapy
Author(s) -
Massimo Breccia
Publication year - 2015
Publication title -
clinical management issues
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2283-3137
pISSN - 1973-4832
DOI - 10.7175/cmi.v4i6s.1096
Subject(s) - medicine , nilotinib , second line , line (geometry) , first line therapy , first line , receptor , tyrosine kinase , geometry , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom